CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation (Q33334431)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation |
scientific article |
Statements
1 reference
CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation (English)
1 reference
Brian Giunta
1 reference
Jared Ehrhart
1 reference
Jun Tan
1 reference
Yuyan Zhu
1 reference
Huayan Hou
1 reference
Elona Rrapo
1 reference
14 May 2008
1 reference
1 reference
e2135
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference